SK280875B6 - Tropánové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a použitie týchto derivátov na výrobu liečiv - Google Patents

Tropánové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a použitie týchto derivátov na výrobu liečiv Download PDF

Info

Publication number
SK280875B6
SK280875B6 SK1288-96A SK128896A SK280875B6 SK 280875 B6 SK280875 B6 SK 280875B6 SK 128896 A SK128896 A SK 128896A SK 280875 B6 SK280875 B6 SK 280875B6
Authority
SK
Slovakia
Prior art keywords
tropane
dichlorophenyl
carbon atoms
cycloalkyl
alkyl
Prior art date
Application number
SK1288-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK128896A3 (en
Inventor
Peter Moldt
Frank W�Tjen
Jorgen Scheel-Kr�Ger
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of SK128896A3 publication Critical patent/SK128896A3/sk
Publication of SK280875B6 publication Critical patent/SK280875B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SK1288-96A 1994-04-19 1995-04-12 Tropánové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a použitie týchto derivátov na výrobu liečiv SK280875B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (2)

Publication Number Publication Date
SK128896A3 SK128896A3 (en) 1997-04-09
SK280875B6 true SK280875B6 (sk) 2000-08-14

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1288-96A SK280875B6 (sk) 1994-04-19 1995-04-12 Tropánové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a použitie týchto derivátov na výrobu liečiv

Country Status (25)

Country Link
US (1) US5736556A (fi)
EP (1) EP0756596B1 (fi)
JP (1) JP2899418B2 (fi)
KR (1) KR100210417B1 (fi)
CN (1) CN1043763C (fi)
AT (1) ATE222587T1 (fi)
AU (1) AU690257B2 (fi)
BG (1) BG63259B1 (fi)
BR (1) BR9507489A (fi)
CA (1) CA2187309C (fi)
CZ (1) CZ284379B6 (fi)
DE (1) DE69527839T2 (fi)
DK (1) DK0756596T3 (fi)
EE (1) EE03877B1 (fi)
FI (1) FI965074A (fi)
GE (1) GEP19991749B (fi)
HU (1) HU215830B (fi)
LV (1) LV11738B (fi)
NO (1) NO964180L (fi)
NZ (1) NZ284075A (fi)
PL (1) PL183025B1 (fi)
RU (1) RU2134264C1 (fi)
SK (1) SK280875B6 (fi)
UA (1) UA49801C2 (fi)
WO (1) WO1995028401A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0859777B1 (en) * 1995-10-13 2007-05-23 Neurosearch A/S 8-azabicyclo(3.2.1)oct-2-ene derivatives, their preparation and use
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
TR199800780T2 (xx) * 1995-11-02 1998-07-21 Neurosearch A/S Kayna�m�� tropan t�revleri, haz�rlan��lar� ve kullan�mlar�.
US5948933A (en) * 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
DK0885220T3 (da) * 1996-02-22 2001-10-15 Neurosearch As Tropanderivater, deres fresmtilling og anvendelse
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
US6417177B1 (en) 1999-07-13 2002-07-09 Alpha Research Group, Llc Chloroquine derivatives for the treatment of Parkinson's disease
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
CZ299102B6 (cs) * 2000-05-26 2008-04-23 Pfizer Inc. Tropanový derivát, zpusoby a meziprodukty pro jeho výrobu, léciva a lécivové kombinace s jeho obsahem
WO2002102801A1 (en) * 2001-05-23 2002-12-27 Neurosearch A/S Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
WO2003045388A1 (en) * 2001-11-30 2003-06-05 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
EP1483237A4 (en) * 2002-03-28 2006-07-05 Harvard College TROPANE COMPOUNDS
US7309790B2 (en) 2003-10-03 2007-12-18 Pfizer Inc Chemical compounds
JP2007508336A (ja) * 2003-10-16 2007-04-05 ニューロサーチ、アクティーゼルスカブ モノアミン神経伝達物質再取り込みインヒビター及びアセチルコリンエステラーゼインヒビターを含む医薬組成物
WO2005070427A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Compounds for the sustained reduction of body weight
CA2554617A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
RU2352332C1 (ru) * 2005-01-14 2009-04-20 Частное Предприятие "Славянская Клиника" Применение местного анестетика для коррекции пищевого поведения человека и способ применения
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds

Also Published As

Publication number Publication date
CZ298296A3 (en) 1997-06-11
DE69527839D1 (en) 2002-09-26
CA2187309A1 (en) 1995-10-26
EP0756596B1 (en) 2002-08-21
RU2134264C1 (ru) 1999-08-10
CN1148854A (zh) 1997-04-30
EE03877B1 (et) 2002-10-15
HUT75865A (en) 1997-05-28
BR9507489A (pt) 1997-08-12
DE69527839T2 (de) 2003-01-02
AU690257B2 (en) 1998-04-23
ATE222587T1 (de) 2002-09-15
HU215830B (hu) 2001-05-28
NZ284075A (en) 1998-01-26
LV11738B (en) 1997-12-20
JPH09505607A (ja) 1997-06-03
BG63259B1 (bg) 2001-07-31
NO964180L (no) 1996-12-16
CA2187309C (en) 2000-11-21
FI965074A0 (fi) 1996-12-17
FI965074A (fi) 1996-12-17
HU9602707D0 (en) 1996-11-28
NO964180D0 (no) 1996-10-02
BG100883A (en) 1998-03-31
CN1043763C (zh) 1999-06-23
DK0756596T3 (da) 2002-12-23
GEP19991749B (en) 1999-09-10
MX9604966A (es) 1998-05-31
PL183025B1 (pl) 2002-05-31
CZ284379B6 (cs) 1998-11-11
UA49801C2 (uk) 2002-10-15
AU2257595A (en) 1995-11-10
KR100210417B1 (ko) 1999-07-15
JP2899418B2 (ja) 1999-06-02
LV11738A (lv) 1997-04-20
SK128896A3 (en) 1997-04-09
WO1995028401A1 (en) 1995-10-26
EP0756596A1 (en) 1997-02-05
US5736556A (en) 1998-04-07
PL316876A1 (en) 1997-02-17
EE9600132A (et) 1997-04-15

Similar Documents

Publication Publication Date Title
SK280875B6 (sk) Tropánové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a použitie týchto derivátov na výrobu liečiv
KR100310663B1 (ko) 트로판유도체,이의제조방법및이를함유하는약제학적조성물
RU2157372C2 (ru) Производные 8-азабицикло[3.2.1.]-окт-2-ена, способ их получения, фармацевтическая композиция, способ изготовления лекарственного средства, способы ингибирования обратного захвата моноаминного нейромедиатора, в особенности серотонина
CZ252098A3 (cs) Tropanové deriváty, způsob jejich přípravy a použití
CA2112084C (en) Antidepressant and antiparkinsonian compounds
US5554626A (en) Substituted heterocyclic compounds as dopamine-reuptake inhibitors
CA2112083C (en) Aryl substituted heterocyclic compounds
EP0604355B1 (en) Akyl Substituted heterocyclic compounds
MXPA96004966A (en) Tropan-2-aldoxine derivatives as inhibitors of neurotransmal restoration